Molecular Biomedicine - Virtual Issue: SARS-CoV-2 (COVID-19) Vaccines
This collection features papers on key topics in COVID-19 research and specifically focuses on vaccines for COVID-19 in this particular issue. All articles have been published and are free to read online. Articles will undergo all of the journal's standard peer review and editorial processes outlined in its submission guidelines. (this opens in a new tab)
Low dose of emetine as potential anti-SARS-CoV-2 virus therapy: preclinical in vitro inhibition and in vivo pharmacokinetic evidences
Wang, A., Sun, Y., Liu, Q. et al.
https://link.springer.com/article/10.1186/s43556-020-00018-9 (this opens in a new tab)
Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid protein
Zhou, R., Zeng, R., von Brunn, A. et al.
https://link.springer.com/article/10.1186/s43556-020-00001-4 (this opens in a new tab)
Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19
Ni, Y., Alu, A., Lei, H. et al.
https://link.springer.com/article/10.1186/s43556-020-00015-y (this opens in a new tab)
Fast and long-lasting immune response to S-trimer COVID-19 vaccine adjuvanted by PIKA
Liu, Y., Dai, L., Feng, X. et al.
https://link.springer.com/article/10.1186/s43556-021-00054-z (this opens in a new tab)
Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?
Srinivasan, K., Pandey, A.K., Livingston, A. et al.
https://link.springer.com/article/10.1186/s43556-021-00060-1 (this opens in a new tab)
Stem cell therapy for COVID-19 pneumonia
Kebria, M.M., Milan, P.B., Peyravian, N. et al.
https://link.springer.com/article/10.1186/s43556-021-00067-8 (this opens in a new tab)
Omicron-included mutation-induced changes in epitopes of SARS-CoV-2 spike protein and effectiveness assessments of current antibodies
Guo, D., Duan, H., Cheng, Y. et al.
https://link.springer.com/article/10.1186/s43556-022-00074-3 (this opens in a new tab)
Trimeric protein vaccine based on Beta variant elicits robust immune response against BA.4/5-included SARS-CoV-2 Omicron variants
He, C., Chen, L., Yang, J. et al
https://link.springer.com/article/10.1186/s43556-023-00121-7 (this opens in a new tab)